Scipher Medicine

Scipher Medicine is driving the probability of success at each stage of drug development from discovery to commercialization by leveraging AI with network biology, and proprietary data, through our SPECTRA Rx and Dx platforms. Scipher has the industry's largest non-oncology clinico-genomic data asset and biobank in addition to EMR data for over 3 million rheumatology patients.

Content by Scipher Medicine

Colorful digital representation of a genetic data sequence displayed in a futuristic style, symbolizing advanced RNA sequencing and molecular data analysis.
| 2 min read
Industry Perspectives
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Researcher examining a multiwell plate alongside cell culture dishes in a laboratory.
Skip RNA purification for faster RT-qPCR workflows
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Webinars
Thermo Fisher Scientific
Abstract rainbow-colored beams of light spreading across a dark background.
How to choose the right fluorochromes for complex flow cytometry panels
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Whitepaper
BD Bio
Illustration of multiple glowing blue and purple spherical cells against a dark blue background.
Technology Guide: High-content analysis in modern drug discovery
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.
Technology Guides
Yokogawa